期刊文献+

登革减毒疫苗研究最新进展及面临的问题 被引量:1

原文传递
导出
摘要 由于近年来登革病毒在全球范围的迅速扩散,登革疫苗的研制成为一个严峻的国际性问题。减毒疫苗是目前最有希望研制成功的,其中传统减毒活疫苗已进入二期临床试验,新型减毒疫苗也显示了自己的优势,但仍面临许多挑战。本文就登革减毒疫苗研究的进展及面临的问题作一综述。
作者 史潇 郑学礼
出处 《热带医学杂志》 CAS 2009年第3期332-334,271,共4页 Journal of Tropical Medicine
基金 国家自然科学基金(No:30872198)。
  • 相关文献

参考文献24

  • 1Guy B, Almond WJ. Towards a dengue vaccine: Progress to date and remaining challenges [J]. Comp Immunol Microbol Infect Dis, 2008,31 (2-3) : 239-252.
  • 2Whitehead SS, Blaney JE, Durbin AP, et al. Prospects for a dengue virus vaccine [ J ]. Nature, 2007,5 : 518-528.
  • 3Edelman R, Wasserman SS, Bodison SA, et al. Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine [J]. Am J Trop Med Hyg, 2003,69(6 suppl):45-60.
  • 4Purl B, Nelson WM, Henchal EA, et al. Molecular analysis of dengue virus attenuation after serial passage in primary dog kidney cell [J]. J Gen Virol, 1997,78:2287-2291.
  • 5Sabehareon A, Lang J, Chanthavanich P, et al. Safety and immunogenicity of a three dose regimen of two tetmvalent live .attenuated dengue vaccines in five-to twelve-year-old Thai children [J]. Pediatr Infect Dis J, 2004,23 (2) :99-109.
  • 6Kitchener S, Nissen M, Nasveld P, et al. Immunogenicity and safety of two live-attenuated teravalent dengue vaccine formulations in healthy Australian adults[J]. Vaccine, 2006, 24: 1238-1241.
  • 7Kanesa-Thasan N, Edelman R, Tacket CO, et al. Phase 1 stuies of Walter Reed Army Institute of Research can didate attenuted dengue vaccines: selection of safe and immunogenic monovalent vaccines [J]. Am J Trop Med Hyg, 2003,69 (Suppl 6) : 17-23.
  • 8Hombach J, Cardosa M J, Sabchareon A, et al. Scientific consultation on immunological correlates of protection induced by dengue vaccinesnext termstar, open Report from a meeting held at the World Health Organization 17-18 November 2005 [J]. Vaccine, 2007,25(21 ) :4130-4139.
  • 9Bhamarapravati N, Sutee Y. Live attenuated tetravalent dengue [J]. Vaccine, 2000,18(Suppl 2) :44-47.
  • 10朱武洋,秦鄂德.新型登革减毒疫苗研究进展[J].军事医学科学院院刊,2006,30(3):268-272. 被引量:1

二级参考文献77

  • 1李绍戊,王荻,冯娟,卢彤岩.养殖鲟鱼出血症病原鲁氏耶尔森菌的分离鉴定和致病性研究[J].海洋与湖沼,2014,45(3):123-129. 被引量:11
  • 2朱武洋,陈水平,秦成峰,于曼,姜涛,邓永强,秦鄂德.登革2型病毒中国分离株感染性全长cDNA克隆的构建与鉴定[J].军事医学科学院院刊,2006,30(2):116-121. 被引量:5
  • 3杨佩英 秦鄂德.登革热和登革出血热[M].北京:人民军医出版社,1999.58-69.
  • 4Bhamarapravati N,Sutee Y.Live attenuated tetravalent dengue vaccine[J].Vaccine,2000,18 (Suppl 2):44-47.
  • 5Chambers TJ.Vaccine development against dengue and Japanese encephalitis:report of a World Health Organization meeting[J].Vaccine,1997,15(14):1494-1502.
  • 6Sabchareon A,Lang J,Chanthavanich P,et al.Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers:role of serotype concentration,ratio,and multiple doses[J].Am J Trop Med Hyg,2002,66(3):264 -272.
  • 7Sabchareon A,Lang J,Chanthavanich P,et al.Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five-to twelve-year-old Thai children[J].Pediatr Infect Dis J,2004,23 (2):99-109.
  • 8Eckels KH,Dubois DR,Putnak R,et al.Modification of dengue virus strains by passage in primary dog kidney cells:preparation of candidate vaccines and immunization of monkeys[J].Am J Trop Med Hyg,2003,69 (Suppl 6):12-16.
  • 9Kanesa-Thasan N,Edelman R,Tacket CO,et al.Phase 1 studies of Walter Reed Army Institute of Research candidate attenuated dengue vaccines:selection of safe and immunogenic monovalent vaccines[J].Am J Trop Med Hyg,2003,69 (Suppl 6):17-23.
  • 10Sun W,Edelman R,Kanesa-Thasan N,et al.Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates[J].Am J Trop Med Hyg,2003,69(Suppl 6):24 -31.

共引文献15

同被引文献17

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部